Your browser doesn't support javascript.
loading
Cystine/Glutamate Antiporter in Schizophrenia: From Molecular Mechanism to Novel Biomarker and Treatment.
Hung, Chung-Chieh; Lin, Chieh-Hsin; Lane, Hsien-Yuan.
Affiliation
  • Hung CC; Institute of Clinical Medical Science, China Medical University, Taichung 40402, Taiwan.
  • Lin CH; Department of Psychiatry, China Medical University Hospital, Taichung 40402, Taiwan.
  • Lane HY; Institute of Clinical Medical Science, China Medical University, Taichung 40402, Taiwan.
Int J Mol Sci ; 22(18)2021 Sep 08.
Article in En | MEDLINE | ID: mdl-34575878

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Antiporters / Glutamic Acid / Cystine / Disease Susceptibility Type of study: Diagnostic_studies / Prognostic_studies Limits: Animals / Humans Language: En Journal: Int J Mol Sci Year: 2021 Document type: Article Affiliation country: Taiwan Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Antiporters / Glutamic Acid / Cystine / Disease Susceptibility Type of study: Diagnostic_studies / Prognostic_studies Limits: Animals / Humans Language: En Journal: Int J Mol Sci Year: 2021 Document type: Article Affiliation country: Taiwan Country of publication: Switzerland